SCHEMBL19239490

SCHEMBL19239490

CN1C(=O)c2ccc3c4c(C(F)(F)F)cc5c6c(ccc(c7c(C(F)(F)F)cc(c2c37)C1=O)c64)C(=O)N(C)C5=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ USP2 O75604 2/20 0.40
▸ KEAP1 Q14145 2/20 0.40
▸ NFE2L2 Q16236 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ TERT O14746 5/20 0.39
▸ POLB P06746 1/20 0.38
▸ PRMT1 Q99873 1/20 0.38
▸ CNR2 P34972 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ALOX15 P16050 1/20 0.34
▸ STAT3 P40763 1/20 0.34
▸ HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19239491 0.89 TERT (0.37) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL17225443 0.86 MEN1 (0.41) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL17225441 0.81 TERT (0.42) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL19245396 0.81 TERT (0.39) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL12869424 0.79 MEN1 (0.42) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL19239500 0.78 CYP1B1 (0.39) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL12108309 0.77 MEN1 (0.44) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL19245363 0.77 TERT (0.41) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL19239492 0.76 KDM4E (0.33) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL12744259 0.76 MEN1 (0.42) MEN1KMT2AALDH1A1USP2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM BASF SE (DE) 2017-08-31 — — US disclosed
US-20170237005-A1 PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL BASF SE (DE) 2017-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM CRY1, NEFM, OR10J3 MEN1 2472/4885KMT2A 4158/4885ALDH1A1 4298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback